Business / Finance

RSS

KineMed renews non-exclusive research collaboration with Pfizer

KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.

4 Jun 2014

Glenmark Pharmaceuticals opens new monoclonal antibody manufacturing facility in Switzerland

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, India (GPL), announced the opening of its new cGMP compliant monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland. T

4 Jun 2014

arGEN-X, Shire Pharmaceuticals announce long-term strategic alliance in therapeutic antibodies

arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a long-term strategic alliance with Shire Pharmaceuticals.

4 Jun 2014

NeuroVive extends collaboration with Hospices Civils de Lyon

NeuroVive is extending its collaboration with Hospices Civils de Lyon (HCL) and Professor Ovize, which broadens the scope of NeuroVive's cardiovascular business area and creates the right conditions for the company to retain its leading position in mitochondrial medicine.

4 Jun 2014

Region Skåne and Sectra sign six-year agreement

Region Skåne, one of Sweden's largest care providers, has signed a six-year agreement with IT and medical technology company Sectra.

4 Jun 2014

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced that it has been awarded funding of £2.2 million towards a Phase IIa clinical trial in tinnitus patients with its lead compound AUT00063, by the UK’s innovation agency, the Technology Strategy Board.

4 Jun 2014

Syngene International, Bristol-Myers Squibb extend drug discovery and development collaboration

Bristol-Myers Squibb and Syngene International, India's largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India.

3 Jun 2014

UK makes £5.64M investment in most advanced crystallography technology

The UK's structural biology community will have access to the most advanced crystallography technology in the world thanks to a - £5.64M investment from UK research funders.

3 Jun 2014

Acadia Healthcare to acquire Partnerships in Care for $660M

Acadia Healthcare Company, Inc. today announced the signing of a definitive agreement to acquire Partnerships in Care (PiC) for approximately $660 million in cash.

3 Jun 2014

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.

3 Jun 2014

Henry Schein acquires France dental distribution business of Sirona Dental Systems

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has acquired Sirona Direct, the France dental distribution business of Sirona Dental Systems, Inc.

3 Jun 2014

Healthcare Trust of America to acquire six MOBs for $200 million

Healthcare Trust of America, Inc. announced today that it was under contract to acquire six medical office buildings ("MOBs") located in major east coast markets, including Boston, Miami and Baltimore for a total consideration of $200 million.

3 Jun 2014

Spherix completes $20M equity financing round

Spherix Incorporated, an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that it has completed a $20 million equity financing consisting of 10 million shares of Series J Convertible Preferred Stock (convertible into common stock) at $2 per share to raise gross proceeds of $20 million, before payment of placement agent fees and other expenses of the offering payable by us.

3 Jun 2014

AMRI agrees to acquire OsoBio for $110 million

AMRI today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC for $110 million in cash.

2 Jun 2014

Endo International subsidiary sells pharmaceutical drug discovery platform to AsanaBioSciences

Endo International plc today announced that its Endo Pharmaceuticals subsidiary has completed the sale of its branded pharmaceutical drug discovery platform to AsanaBioSciences, LLC, an independent member of the Amneal Alliance of Companies.

2 Jun 2014

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

Medical Equipment Solutions and Applications, Europe's leader in multi-vendor service for Diagnostic Imaging systems, equipment and parts, and Heidelberg-based radiology management company Curagita are joining forces to bring new and broader solutions for a full range of Diagnostic Imaging services to the German healthcare market.

2 Jun 2014

Cherokee Health Systems selects NextGen Healthcare to provide RCM services

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today that Cherokee Health Systems has selected NextGen Healthcare to provide revenue cycle management (RCM) services to re-engineer its business processes, improve financial results and drive business growth.

2 Jun 2014

Pivotal Therapeutics reports reduced revenue in first quarter 2014

Pivotal Therapeutics Inc., ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2014.

31 May 2014

Valeant, Pershing Square make revised proposal to acquire all outstanding shares of Allergan

Allergan, Inc. ("Allergan" or the "Company") today acknowledged that Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") have made a second revised, unsolicited proposal to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares, $72.00 in cash per share of common stock of the Company, and a Contingent Value Right (CVR) related to DARPin® sales (the "Re-Revised Proposal").

31 May 2014

MediNatura to purchase Heel Group's USA operation

MediNatura™ Incorporated, a Delaware Corporation headquartered in greater Philadelphia, today announced an agreement to purchase the Heel Group's USA operations, which is expected to be completed in late August 2014.

31 May 2014

Business / Finance

KineMed renews non-exclusive research collaboration with Pfizer

Glenmark Pharmaceuticals opens new monoclonal antibody manufacturing facility in Switzerland

arGEN-X, Shire Pharmaceuticals announce long-term strategic alliance in therapeutic antibodies

NeuroVive extends collaboration with Hospices Civils de Lyon

Region Skåne and Sectra sign six-year agreement

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Syngene International, Bristol-Myers Squibb extend drug discovery and development collaboration

UK makes £5.64M investment in most advanced crystallography technology

Acadia Healthcare to acquire Partnerships in Care for $660M

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Henry Schein acquires France dental distribution business of Sirona Dental Systems

Healthcare Trust of America to acquire six MOBs for $200 million

Spherix completes $20M equity financing round

AMRI agrees to acquire OsoBio for $110 million

Endo International subsidiary sells pharmaceutical drug discovery platform to AsanaBioSciences

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

Cherokee Health Systems selects NextGen Healthcare to provide RCM services

Pivotal Therapeutics reports reduced revenue in first quarter 2014

Valeant, Pershing Square make revised proposal to acquire all outstanding shares of Allergan

MediNatura to purchase Heel Group's USA operation

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News